Lucilla Parnetti
USERN Advisory Board
Lucilla Parnetti, MD, PhD, is a docent of neurology at the University of Perugia School of Medicine in Italy. She has wide experience in the field of neurodegenerative disease research, and her activity includes clinical characterization of patients with dementia and research on biomarker discovery and validation. Her main expertise is in the field of cerebrospinal fluid biomarkers for early diagnosis of neurodegenerative diseases, with special interest in Alzheimer’s disease and Parkinson’s disease. Dr. Parnetti has worked on national and international projects on the role of lysosome dysfunction in Parkinson’s disease.
Institutions:
University of Perugia until present
Affiliations:
Clinica Neurologica, Università degli Studi di Perugia, Perugia, Italy
Frontiers
Country Coordinator for Italy - JPND-BIOMARKAPD
Most cited publications:
The mental deterioration battery: Normative data, diagnostic reliability and qualitative analyses of cognitive impairment
Authors: Carlesimo, GA; Caltagirone, C; Gainotti, G; ... Parnetti, L
Published: Jan 1996 in European Neurology
DOI: 10.1159/000117297
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Authors: Mattsson, Niklas; Zetterberg, Henrik; Hansson, Oskar; ... Blennow, Kaj
Published: Jul 2009 in JAMA
DOI: 10.1001/JAMA.2009.1064
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Authors: Mattsson, Niklas; Andreasson, Ulf; Persson, Staffan; ... Blennow, Kaj
Published: Jul 2011 in Alzheimer's & Dementia: The Journal of the Alzheimer's Association
DOI: 10.1016/J.JALZ.2011.05.2243
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance
Authors: Calabresi, Paolo; Picconi, Barbara; Parnetti, Lucilla; Di Filippo, Massimiliano
Published: 2006 in The Lancet Neurology
DOI: 10.1016/S1474-4422(06)70600-7
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
Authors: Vanderstichele, Hugo; Bibl, Mirko; Engelborghs, Sebastiaan; ... Blennow, Kaj
Published: Jan 2012 in Alzheimer's & Dementia: The Journal of the Alzheimer's Association
DOI: 10.1016/J.JALZ.2011.07.004
Institutions:
University of Perugia until present
Affiliations:
Clinica Neurologica, Università degli Studi di Perugia, Perugia, Italy
Frontiers
Country Coordinator for Italy - JPND-BIOMARKAPD
Most cited publications:
The mental deterioration battery: Normative data, diagnostic reliability and qualitative analyses of cognitive impairment
Authors: Carlesimo, GA; Caltagirone, C; Gainotti, G; ... Parnetti, L
Published: Jan 1996 in European Neurology
DOI: 10.1159/000117297
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Authors: Mattsson, Niklas; Zetterberg, Henrik; Hansson, Oskar; ... Blennow, Kaj
Published: Jul 2009 in JAMA
DOI: 10.1001/JAMA.2009.1064
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Authors: Mattsson, Niklas; Andreasson, Ulf; Persson, Staffan; ... Blennow, Kaj
Published: Jul 2011 in Alzheimer's & Dementia: The Journal of the Alzheimer's Association
DOI: 10.1016/J.JALZ.2011.05.2243
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance
Authors: Calabresi, Paolo; Picconi, Barbara; Parnetti, Lucilla; Di Filippo, Massimiliano
Published: 2006 in The Lancet Neurology
DOI: 10.1016/S1474-4422(06)70600-7
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
Authors: Vanderstichele, Hugo; Bibl, Mirko; Engelborghs, Sebastiaan; ... Blennow, Kaj
Published: Jan 2012 in Alzheimer's & Dementia: The Journal of the Alzheimer's Association
DOI: 10.1016/J.JALZ.2011.07.004
No items yet!
No items yet!